What are the Policy Limitations Factoring into Consumers’ Ability to Benefit from Functional Foods?
Sometimes regulatory compliance results in misleading, if not outright false, statements of the underlying science. To avoid classification of a food as a drug, some claims (e.g., structure/function claims) on foods may not accurately convey the actual effects of the food and, hence, confuse consumers. For example, a claim that a food lowers cholesterol would be considered a drug claim because it implies abnormal cholesterol levels. Thus, functional foods that affect cholesterol levels state that the food “maintains normal cholesterol levels,” a permissible structure/function claim. However, such a statement is potentially misleading if the food in fact lowers cholesterol levels.
Related Questions
- My college has informed me that I need to take an Ability to Benefit (ATB) exam in order to be eligible for the Tuition Assistance Program (TAP) and Scholarships. What exactly is meant by ATB?
- Where can I get the full Policy Wordings and Benefit Details of my Tiger Purrtection Travel Insurance Policy?
- Are there Policy Limitations Hindering Development, Commercialization, and Consumers’ Use of Functional Foods?
